Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of postoperative deep venous thrombosis and pulmonary embolism.

Literature DB >> 5100262

Prevention of postoperative deep venous thrombosis and pulmonary embolism.

Abstract

Two series of patients observed clinically and by phlebography suggest that one agent known to produce a reduction in platelet aggregation in vitro might be useful in reducing the incidence of deep venous thrombosis and pulmonary embolism postoperatively. The agent used in this study was hydroxychlorquine sulphate.

Entities: Chemical Disease Species

Mesh：
Aged
Humans

Year: 1971 PMID： 5100262 PMCID： PMC1794857 DOI： 10.1136/bmj.1.5744.312

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

6 in total

1. PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.

Authors: S SEVITT; D INNES
Journal: Lancet Date: 1964-01-18 Impact factor: 79.321

2. THE AGGREGATION OF BLOOD PLATELETS.

Authors: G V BORN; M J CROSS
Journal: J Physiol Date: 1963-08 Impact factor: 5.182

3. Use of antimalarial drugs as "desludging" agents in vascular disease processes.

Authors: B P MADOW
Journal: J Am Med Assoc Date: 1960-04-09

4. Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis.

Authors: N L Browse; J H Hall
Journal: Lancet Date: 1969-10-04 Impact factor: 79.321

5. The post-mortem incdence of pulmonary embolism in a hospital population.

Authors: M T Morrell; M S Dunnill
Journal: Br J Surg Date: 1968-05 Impact factor: 6.939

6. 125-I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography.

Authors: D Negus; D J Pinto; L P Le Quesne; N Brown; M Chapman
Journal: Br J Surg Date: 1968-11 Impact factor: 6.939

6 in total

11 in total

1. [Platelet chloroquine and serotonin. Demonstration of competitive inhibition of serotonin uptake].

Authors: M Lagarde; M Dechavanne; P A Bryon
Journal: Experientia Date: 1975-02-15

Review 2. Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.

Authors: Michelle Petri
Journal: Curr Rheumatol Rep Date: 2011-02 Impact factor: 4.592

Review 3. Platelets, thrombosis and drugs.

Authors: J F Mustard; M A Packham
Journal: Drugs Date: 1975 Impact factor: 9.546

4. Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors: E W Salzman; G C Davies
Journal: Ann Surg Date: 1980-02 Impact factor: 12.969

5. Use of chloroquine in shock.

Authors: C E Famewo; W H Noble; M B Garvey
Journal: Can Anaesth Soc J Date: 1975-11

Review 6. Antithrombotic drugs: part II.

Authors: A S Gallus; J Hirsh
Journal: Drugs Date: 1976 Impact factor: 9.546

7. Asymptomatic pulmonary embolism. A common event in high risk patients.

Authors: J W Williams; E A Eikman; S Greenberg
Journal: Ann Surg Date: 1982-03 Impact factor: 12.969

8. Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate.

Authors: A E Carter; R Eban
Journal: Br Med J Date: 1974-07-13

Review 9. Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors: A S Gallus
Journal: Drugs Date: 1979-12 Impact factor: 9.546

10. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study.

Authors: Elisabeth Pasquier; Luc de Saint-Martin; Gisèle Marhic; Celine Chauleur; Caroline Bohec; Florence Bretelle; Véronique Lejeune-Saada; Jacob Hannigsberg; Geneviève Plu-Bureau; Virginie Cogulet; Philippe Merviel; Dominique Mottier
Journal: BMJ Open Date: 2019-03-20 Impact factor: 2.692